Pulmonology & Respiratory Medicine Command Center
High-yield pulmonary pathophysiology, pulmonary function tests (PFT) flow-volume loop interpretation, alveolar gas equation and A-a gradient hypoxemia mechanics, pulmonary embolism risk stratification, pneumonia hepatization pathology, and ARDS mechanical ventilation protocols.
Obstructive vs. Restrictive Deficit Decoder
| Parameter | Obstructive Pattern | Restrictive (Intrinsic / IPF) | Restrictive (Extrinsic / Chest Wall) | Board Exam Pivot Point |
|---|---|---|---|---|
| FEV1 / FVC | < 0.70 (< 70%) | Normal or > 0.70 (> 70%) | Normal or > 0.70 (> 70%) | First step in algorithm: < 0.70 definitively establishes obstruction. |
| FEV1 | ↓↓↓ (Markedly reduced) | ↓ (Reduced proportionally) | ↓ (Reduced proportionally) | Used to grade severity in COPD (GOLD 1 ≥80% to GOLD 4 <30%). |
| FVC | Normal or ↓ (air trapping) | ↓↓ (Reduced lung expansion) | ↓↓ (Restricted excursion) | If FVC is reduced with normal FEV1/FVC, must order lung volumes (TLC). |
| TLC (Total Lung Capacity) | ↑ (Hyperinflation / air trapping) | < 80% predicted (Defines Restriction) | < 80% predicted | TLC < 80% is the gold standard requirement to confirm restriction. |
| RV (Residual Volume) | ↑↑ (Loss of elastic recoil) | ↓ (Stiff non-compliant lungs) | Normal or ↑ (weak expiratory muscle) | Myasthenia gravis/ALS often has elevated RV/TLC ratio due to diaphragm weakness. |
| DLCO (Diffusing Capacity) |
↓ in Emphysema Normal in Chronic Bronchitis Normal/↑ in Asthma |
↓↓ (Alveolar-capillary membrane fibrosis) | Normal (Normal alveolar membrane) | DLCO distinguishes intrinsic lung disease (fibrosis, emphysema) from chest wall/neuromuscular restriction! |
Bronchiectasis: "Signet Ring" Sign
Imaging Clue: Bronchodilation where the internal bronchial diameter exceeds the adjacent pulmonary artery branch diameter (bronchoarterial ratio > 1.0) creating a classic "signet ring".
Clinical Triad: Chronic daily purulent sputum production, hemoptysis, recurrent pneumonias.
Etiologies: Cystic Fibrosis (CFTR mutation, Pseudomonas, allergic bronchopulmonary aspergillosis ABPA), Kartagener syndrome (primary ciliary dyskinesia, dynein arm defect, situs inversus, sinusitis, infertility).
UIP Pattern: Subpleural Honeycombing
Imaging Clue: Bilateral peripheral and basilar-predominant reticular opacities with subpleural clustered cyst formation ("honeycombing") and traction bronchiectasis.
Histopathology: Usual Interstitial Pneumonia (UIP) showing spatial and temporal heterogeneity with fibroblastic foci alternating with normal lung parenchyma.
Targeted Therapeutics: Pirfenidone (anti-fibrotic, inhibits TGF-beta) and Nintedanib (tyrosine kinase inhibitor targeting VEGF/FGF/PDGF); immunosuppression/corticosteroids worsen mortality in IPF!
Pneumoconioses & Granulomatous Matrix
Occupational Risk: Sandblasting, foundries, quartz quarries, ceramics, mining.
Pathology: Macrophages ingest silica crystals → lysosomal rupture and release of fibrogenic cytokines → dense hyalinized nodules with polarized birefringence.
Board Landmark: "Eggshell" calcification of hilar lymph nodes; impairs macrophage phagolysosome function, causing a 30-fold increased risk of active Tuberculosis.
Occupational Risk: Shipbuilding, roofing, plumbing, brake pad lining, insulation installation.
Pathology: Golden-brown fusiform dumbbell-shaped ferruginous bodies (asbestos fibers coated with iron and protein, stains with Prussian blue).
Board Landmark: Ivory-white calcified supradiaphragmatic pleural plaques; much higher risk of Bronchogenic Carcinoma than malignant mesothelioma (though mesothelioma is pathognomonic).
Demographics: Young African American females, non-smokers, constitutional fatigue, erythema nodosum, uveitis (Löfgren syndrome).
Pathology: Non-caseating epithelioid granulomas containing multinucleated giant cells with asteroid bodies and Schaumann bodies; CD4/CD8 ratio > 3.5 in BAL.
Biochemical Markers: Elevated serum ACE and hypercalcemia/hypercalciuria (due to 1-α-hydroxylase production by epithelioid macrophages generating active 1,25-(OH)2 vitamin D).
